We are developing "first-in-class" and "best-in-class" global innovative new drugs.Hwangeun Choi, PhD
The in silico molecular design platform with virtual screening allows Voronoi to quickly discover hit compounds, and accelerate predicting efficacy and pharmacological value.Kim Namdoo, PhD
